Fig. 1.
Fig. 1. Clustering of membrane rafts and Fas in ET-18-OCH3–treated Jurkat cells. / (A) Time course of the effect of ET-18-OCH3 on aggregation of membrane rafts. T-leukemic Jurkat cells, grown in 10% FCS-containing medium, were either untreated (Control) or treated with 5 μg/mL ET-18-OCH3 for the times indicated. Cells were then stained with FITC-CTx and analyzed by confocal microscopy. Bar indicates 7 μm. (B) Colocalization of membrane rafts (Raft) and Fas in ET-18-OCH3–treated Jurkat cells. Cells were either untreated (Control) or treated with 5 μg/mL ET-18-OCH3for 3 hours, and processed for confocal microscopy using FITC-CTx (green fluorescence for lipid rafts) and anti-Fas mAb, followed by CY3-conjugated antimouse antibody (red fluorescence for Fas). Areas of colocalization between membrane rafts and Fas in the overlay panels are yellow. Bar indicates 10 μm.

Clustering of membrane rafts and Fas in ET-18-OCH3–treated Jurkat cells.

(A) Time course of the effect of ET-18-OCH3 on aggregation of membrane rafts. T-leukemic Jurkat cells, grown in 10% FCS-containing medium, were either untreated (Control) or treated with 5 μg/mL ET-18-OCH3 for the times indicated. Cells were then stained with FITC-CTx and analyzed by confocal microscopy. Bar indicates 7 μm. (B) Colocalization of membrane rafts (Raft) and Fas in ET-18-OCH3–treated Jurkat cells. Cells were either untreated (Control) or treated with 5 μg/mL ET-18-OCH3for 3 hours, and processed for confocal microscopy using FITC-CTx (green fluorescence for lipid rafts) and anti-Fas mAb, followed by CY3-conjugated antimouse antibody (red fluorescence for Fas). Areas of colocalization between membrane rafts and Fas in the overlay panels are yellow. Bar indicates 10 μm.

Close Modal

or Create an Account

Close Modal
Close Modal